Prevention of Acute Graft-Versus-Host Disease in Human/Mouse Xenogeneic SCID Mouse Model by Humanized Anti-CD74 Monoclonal Antibody, Milatuzumab

被引：0
|
作者：
Chen, Xiaochuan [1 ]
Chang, Chien-Hsing [2 ]
Stein, Rhona [1 ]
Cardillo, Thomas M. [2 ]
Gold, David V. [1 ]
Goldenberg, David M. [1 ]
机构：
[1] Garden State Canc Ctr, Ctr Mol Med & Immunol, Morris Plains, NJ USA
[2] Immunomedics Inc, R&D, Morris Plains, NJ USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.4105.4105
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4105
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A HUMAN-MODEL OF XENOGENEIC GRAFT-VERSUS-HOST DISEASE IN SCID MICE ENGRAFTED WITH HUMAN PERIPHERAL-BLOOD LYMPHOCYTES
    SANDHU, JS
    GORCZYNSKI, R
    SHPITZ, B
    GALLINGER, S
    NGUYEN, HP
    HOZUMI, N
    [J]. TRANSPLANTATION, 1995, 60 (02) : 179 - 184
  • [32] Prevention of xenogeneic graft-versus-host disease strengthens the engraftment of human acute myeloid leukaemia in NOD/SCID/IL2rgamma-/- mice
    von Bonin, M.
    Wermke, M.
    Thiede, C.
    Bornhaeuser, M.
    Waskow, C.
    [J]. BONE MARROW TRANSPLANTATION, 2012, 47 : S118 - S118
  • [33] Protection from graft-versus-host disease with a novel B7 binding site-specific mouse anti-mouse CD28 monoclonal antibody
    Beyersdorf, Niklas
    Ding, Xin
    Blank, Gregor
    Dennehy, Kevin M.
    Kerkau, Thomas
    Huenig, Thomas
    [J]. BLOOD, 2008, 112 (10) : 4328 - 4336
  • [34] Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFα antibody
    Kobbe, G
    Schneider, P
    Rohr, U
    Fenk, R
    Neumann, F
    Aivado, M
    Dietze, L
    Kronenwett, R
    Hünerlitürkoglu, A
    Haas, R
    [J]. BONE MARROW TRANSPLANTATION, 2001, 28 (01) : 47 - 49
  • [35] Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFα antibody
    G Kobbe
    P Schneider
    U Rohr
    R Fenk
    F Neumann
    M Aivado
    L Dietze
    R Kronenwett
    A Hünerlitürkoglu
    R Haas
    [J]. Bone Marrow Transplantation, 2001, 28 : 47 - 49
  • [36] TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE WITH ANTI-CD3 MONOCLONAL-ANTIBODIES
    MARTIN, PJ
    HANSEN, JA
    ANASETTI, C
    ZUTTER, M
    DURNAM, D
    STORB, R
    THOMAS, ED
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1988, 11 (02) : 149 - 152
  • [37] Human mesenchymal stem cells suppress donor CD4+T cell proliferation and reduce pathology in a humanized mouse model of acute graft-versus-host disease
    Tobin, L. M.
    Healy, M. E.
    English, K.
    Mahon, B. P.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2013, 172 (02): : 333 - 348
  • [38] PREVENTION OF LETHAL GRAFT-VERSUS-HOST DISEASE BY MONOCLONAL-ANTIBODY TREATMENT INVIVO
    KNULST, AC
    TIBBE, GJM
    BRILBAZUIN, C
    BENNER, R
    [J]. TRANSPLANT INTERNATIONAL, 1992, 5 : S504 - S505
  • [39] Pharmacological blockade of the CD39/CD73 pathway but not adenosine receptors augments disease in a humanized mouse model of graft-versus-host disease
    Geraghty, Nicholas J.
    Watson, Debbie
    Sluyter, Ronald
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2019, 97 (06): : 597 - 610
  • [40] Humanized Anti-CD25 Monoclonal Antibody Replacing MTX for Graft-Versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplantation
    Huang, Zhenli
    Zhang, Ran
    Small, Donald
    Zhu, Ruiqi
    Shi, Wei
    Xia, Linghui
    [J]. BLOOD, 2023, 142
12345